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Abstract
In this work, we are interested in predicting the diagnostic statuses of potentially
neurodegenerated patients using feature values derived from multi-modality neuroimaging data
and biological data, which might be incomplete. Collecting the feature values into a matrix, with
each row containing a feature vector of a sample, we propose a framework to predict the
corresponding associated multiple target outputs (e.g., diagnosis label and clinical scores) from
this feature matrix by performing matrix shrinkage following by matrix completion. Specifically,
we first combine the feature and target output matrices into a large matrix and then partition this
large incomplete matrix into smaller submatrices, each consisting of samples with complete
feature values (corresponding to a certain combination of modalities) and target outputs. Treating
each target output as the outcome of a prediction task, we apply a 2-step multi-task learning
algorithm to select the most discriminative features and samples in each submatrix. Features and
samples that are not selected in any of the submatrices are discarded, resulting in a shrunk version
of the original large matrix. The missing feature values and unknown target outputs of the shrunk
matrix is then completed simultaneously. Experimental results using the ADNI dataset indicate
that our proposed framework achieves higher classification accuracy at a greater speed when
compared with conventional imputation-based classification methods and also yields competitive
performance when compared with the state-of-the-art methods.
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Alzheimers Disease (AD) is the most prevalent form of dementia. It is ultimately fatal and is
ranked as the sixth leading cause of death in United States in year 2012 (Alzheimer’s
Association, 2013). Neurodegeneration associated with AD is progressive and the symptoms
usually begin with gradual memory decline followed by a gradual loss of cognitive and
motor abilities that will cause difficulties in the daily lives of the patients. Eventually, the
patients will lose the ability to take care of themselves and will need to rely on the intensive
care provided by others. This has posed significant medical and socioeconomic challenges to
the community (Alzheimer’s Association, 2013).
Owing to the criticality of this issue, it is vital to diagnose AD accurately, especially at its
prodormal stage, i.e., amnestic mild-cognitive impairment (MCI), so that an early treatment
can be provided to possibly stop or slow down the progression of the disease. MCI, which is
defined as a condition where the patient has noticeable cognitive decline, but with-out
difficulty in carrying out daily activities, has high probability to develop into AD. With the
help of emerging neuroimaging technology, the progress and severity of the
neurodegeneration associated with AD or MCI can now be diagnosed and monitored in
different ways (modalities). Magnetic resonance imaging (MRI) scans, for instance, provide
3D structural information about the brain, where features such as region-of-interest (ROI)-
based volumetric measure and the cortical thickness can be extracted from the MRI to
quantify brain atrophy that is usually associated with the diseases (Du et al., 2007; Fan et al.,
2007; Klöppel et al., 2008; Desikan et al., 2009; Oliveira Jr et al., 2010; Gerardin et al.,
2009; Cuingnet et al., 2011). Flourodeoxyglucose positron emission tomography (FDG-
PET), on the other hand, can be used to detect abnormality in term of glucose metabolic rate
at brain regions preferentially affected by AD (Higdon et al., 2004; Foster et al., 2007;
Chetelat et al., 2003; Chételat et al., 2005; Herholz et al., 2002). Beside neuroimaging
techniques, another line of research uses biological and genetic data to develop potential
biomarkers for AD diagnosis. The important measurements in biological and genetic data
that are closely related to cognitive decline in AD patients include the increase of
cerebrospinal fluid (CSF) total-tau (t-tau) and CSF tau hyperphosphorylated at threonine 181
(p-tau), the decrease of CSF amyloid β (Aβ), and the presence of gene apolipoprotein E
(APOE) ∊4 allele (Fagan et al., 2007; Morris et al., 2009; Fjell et al., 2010).
Although it is common to use information from only one modality such as structural MRI
for diagnosis of AD/MCI, complementary information from multiple modalities (Fjell et al.,
2010; Walhovd et al., 2010; Landau et al., 2010; Zhang et al., 2011; Liu et al., 2014) can be
combined for more accurate diagnosis. This is supported by the results reported in recent
studies (De Leon et al., 2006; Fan et al., 2008; Ye et al., 2008; Hinrichs et al., 2009, 2011;
Davatzikos et al., 2011; Zhang and Shen, 2012; Zhang et al., 2011; Liu et al., 2013). To
support AD research using multi-modality data, Alzheimer’s Disease Neuroimaging
Initiative (ADNI) has been actively collecting data from multiple modalities (e.g., MRI,
FDG-PET and CSF data) from AD, MCI and normal control (NC) subjects yearly or half-
yearly. Unfortunately, not all the samples in ADNI dataset are completed with the data from
all different modalities. For example, while all the samples in the ADNI baseline dataset
contain MRI data, only about half of the samples contain FDG-PET data (which is referred
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as PET throughout the manuscript) and another different half of the samples contain CSF
data. The “missing” data in the ADNI dataset is due to several reasons, such as, high
measurement cost (i.e., PET scans), poor data quality and unwillingness of the patients to
receive invasive tests (i.e., collection of CSF samples through lumber puncture).
There are basically two approaches to deal with missing data in a dataset, i.e., we can either
1) discard the samples with missing data, or 2) impute the missing data. Most existing
approaches discard samples with at least one missing modality and perform disease
identification based on the remainder of the dataset. However, this approach discards a lot of
information that is potentially useful. In fact, if following this approach for multi-modality
analysis using MRI, PET and CSF data, about 2/3 of the total samples at ADNI baseline
dataset will have to be removed.
The data imputation approach, on the other hand, is more preferable as it provides the
possibility to use as many samples as possible in analysis. In fact, incomplete dataset is
ubiquitous in many applications and thus various imputation methods have been developed
to estimate the missing values based on the available data (Schneider, 2001; Troyanskaya et
al., 2001; Zhu et al., 2011). However, these methods work well only when a small portion of
the data is missing, but become less effective when a large portion of the data is missing
(e.g., PET data in ADNI). Recently, low rank matrix completion (Candès and Recht, 2009)
has been proposed to impute missing values in a large matrix through trace norm
minimization. This algorithm can effectively recover a large portion of the missing data if
the ground truth matrix is low rank and if the missing data are distributed randomly and
uniformly (Candès and Recht, 2009). Unfortunately, the latter assumption does not hold in
our case since, for each subject, the data from one or more of the modalities might be
entirely missing, i.e., the data is missing in blocks.
In this paper, we attempt to identify AD and MCI from the NCs using incomplete multi-
modality dataset from the ADNI database. Denoting the incomplete dataset as a matrix with
each row representing a feature vector derived from multi-modality data of a sample,
conventional approach for solving this problem is to impute the missing data and build a
classifier based on the completed matrix. However, it is too time consuming (as matrix size
is large) (Xu and Jordan, 1996; Jollois and Nadif, 2007) and inaccurate (as there are too
many missing values) to apply the current imputation methods directly. In addition, the
errors introduced during the imputation process may affect the performance of the classifier.
In this paper, we largely avert the problems of the conventional approach by proposing a
framework that 1) shrinks the large incomplete matrix through feature and sample
selections, and 2) predicts the output labels directly through matrix completion on the
shrunk matrix (i.e., without building another classifier on the completed matrix).
Specifically, we first partition the incomplete dataset into two portions -training set and
testing set. Each set is represented by an incomplete feature matrix (each row contains
feature vector of a sample), and a corresponding target output matrix (i.e., diagnostic status
and clinical scores). Our first goal is to remove redundant/noisy features and samples from
the feature matrix so that the imputation problem can be simplified. However, due to the
missing values in the feature matrix, feature and sample selections can not be performed
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directly. We thus partition the feature matrix, together with the target output matrix, into
submatrices with only complete data (Ghannad-Rezaie et al., 2010), so that a 2-step multi-
task learning algorithm (Obozinski et al., 2006; Zhang and Shen, 2012) can be applied to
these sub-matrices to obtain a set of discriminative features and samples. The selected
features and samples then form a shrunk, but still incomplete, matrix which is more
“friendly” to imputation algorithms, as redundant/noisy features and samples have been
removed and there are now a smaller number of missing values that need to be imputed. We
propose to impute the missing feature data and target outputs simultaneously using a matrix
completion approach. Two matrix completion algorithms are explored: low rank matrix
completion and expectation maximization (EM). Experimental results demonstrate that our
framework yields faster imputation and more accurate prediction of diagnostic labels than
the conventional imputation-based classification approach.
In brief, we propose a framework for a solution for this problem - classification using
incomplete multi-modality data with large block of missing data. The contributions of our
framework are summarized below:
• Feature selection using incomplete matrix (i.e., matrix with missing values) through
data grouping and multi-task learning.
• Sample selection using incomplete matrix through data grouping and multi-task
learning.
• Improve imputation effectiveness by focusing only on the imputation of important
data.
• Improve classification performance by label imputation.
2. Data
2.1. ADNI background
Data used in the preparation of this article were obtained from the ADNI database
(adni.loni.ucla.edu). The ADNI was launched in 2003 by the National Institute on Aging
(NIA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Food
and Drug Administration (FDA), private pharmaceutical companies and non-profit
organizations, as a $60 million, 5-year public-private partnership. The primary goal of
ADNI has been to test whether serial MRI, PET, other biological markers, and clinical and
neuropsychological assessment can be combined to measure the progression of MCI and
early AD. Determination of sensitive and specific markers of very early AD progression is
intended to aid researchers and clinicians to develop new treatments and monitor their
effectiveness, as well as lessen the time and cost of clinical trials.
The Principal Investigator of this initiative is Michael W. Weiner, MD, VA Medical Center
and University of California - San Francisco. ADNI is the result of efforts of many co-
investigators from a broad range of academic institutions and private corporations, and
subjects have been recruited from over 50 sites across the U.S. and Canada. The initial goal
of ADNI was to recruit 800 subjects but ADNI has been followed by ADNI-GO and
ADNI-2. To date, these three protocols have recruited over 1500 adults, ages 55 to 90, to
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participate in the research, consisting of cognitively normal older individuals, people with
early or late MCI, and people with early AD. The follow up duration of each group is
specified in the protocols for ADNI-1, ADNI-2 and ADNI-GO. Subjects originally recruited
for ADNI-1 and ADNI-GO had the option to be followed in ADNI-2. For up-to-date
information, see www.adni-info.org.
2.2. Subjects
We only used the baseline data in this study, amounting to a total of 807 subjects (186 AD,
395 MCI and 226 NC). All 807 subjects have MRI scanned, while only 397 subjects have
FDG-PET scanned and 406 subjects have CSF sampled. The general inclusion/exclusion
criteria used by ADNI are summarized as follow: 1) Normal subjects: Mini-Mental State
Examination (MMSE) scores between 24–30 (inclusive), a Clinical Dementia Rating (CDR)
of 0, non-depressed, non MCI, and nondemented; 2) MCI subjects: MMSE scores between
24–30 (inclusive), a memory complaint, have objective memory loss measured by education
adjusted scores on Wechsler Memory Scale Logical Memory II, a CDR of 0.5, absence of
significant levels of impairment in other cognitive domains, essentially preserved activities
of daily living, and an absence of dementia; 3) mild AD: MMSE scores between 20–26
(inclusive), CDR of 0.5 or 1.0, and meets NINCDS/ADRDA criteria for probable AD.
Since MMSE and CDR were used as parts of the criteria in categorizing subjects to different
disease groups in ADNI dataset, they might provide complementary information in the data
imputation process. Thus, in this study, three clinical scores were also included (CDR
global, CDR-SB1 and MMSE) as target outputs in addition to target label. The information
of the subjects (i.e., gender, age and education) and clinical scores (i.e., MMSE and CDR
global) used in this study are summarized in Table 1.
2.3. Data processing
The MRI and PET images were pre-processed to extract ROI-based features. For the
processing of MRI images, anterior commissure (AC) - posterior commissure (PC)
correction was first applied to all the images using MIPAV software2. We then resampled
the images to 256 × 256 × 256 resolution and used N3 algorithm (Sled et al., 1998) to
correct the intensity inhomogeneity. Next, the skull was stripped using the method described
in (Wang et al., 2011), followed by manual editing and cerebellum removal. We then used
FAST (Zhang et al., 2001) in the FSL package3 to segment the human brain into three
different types of tissues: grey matter (GM), white matter (WM) and cerebrospinal fluid
(CSF). After registration using HAMMER (Shen and Davatzikos, 2002), we obtained the
subject-labeled image based on a template with 93 manually labeled region-of-interests
(ROIs) (Kabani, 1998). For each subject, we used the volumes of GM tissue of the 93 ROIs,
which were normalized by the total intracranial volume (which is estimated by the
summation of GM, WM and CSF volumes from all ROIs), as features. For PET image, we
first aligned it to its corresponding MRI image of the same subject through affine
transformation, and then computed the average intensity of each ROI in the PET image as
1CDR-SB: CDR Sum of Box, summation of six CDR subscores.
2http://mipav.cit.nih.gov/index.php
3http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/
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feature. In addition, five CSF biomarkers were also used in this study, namely amyloid β
(Aβ42), CSF total tau (t-tau) and tau hyperphosphorylated at threonine 181 (p-tau) and two
tau ratios with respective to Aβ42 (i.e., t-tau/Aβ42 and p-tau/Aβ42). As a result, there are a
total of 93 features derived from the MRI images, 93 features derived from the PET images
and 5 features derived from the CSF biomarkers used in this study. Table 2 summarizes the
number of samples and the number of features used in this study for each modality. The
numbers under the column “All” represent the number of samples with all the three
modalities available.
3. Classification through matrix shrinkage and completion
Figure 1 illustrates our framework, which consisted of three components: 1) feature
selection, 2) sample selection, and 3) matrix completion. Let X ∈ ℝn×d (n samples, d
features) and Y ∈ ℝn×t (n samples, t targets) denote the feature matrix (that contains features
derived from MRI, PET and CSF data) and target matrix (that contains label [−1 1] and
clinical scores), respectively. As shown in the leftmost diagram in Figure 1, X is incomplete,
and about half of the subjects do not have PET and CSF data. The dataset is divided into two
parts, one for training and one for testing. The target outputs for all the training samples are
known, but the target outputs for the testing samples are set to unknown for testing purposes.
The input features X and clinical scores of Y are first z-normalized across all the samples, by
using mean and scale obtained only from the training data. All the missing data are ignored
during the normalization process. Then, two stages of multi-task sparse regression are used
to remove noisy or redundant features and samples in the training set. The remaining matrix
is a matrix with the most discriminative features and samples from the training set. The
same set of features selected in the training set are also selected for the testing set. The
shrunk training feature matrix together with the testing feature matrix forms a shrunk feature
matrix Xs. We then stack Xs with the corresponding target outputs Ys (where the values is
unknown for the testing set) to form an incomplete matrix Z. Finally, a matrix completion
algorithm (Goldberg et al., 2010; Ma et al., 2011; Schneider, 2001) is applied to Z, so that
missing features and the unknown testing target outputs can be predicted simultaneously.
The signs of the imputed target labels are then used as the classification output for the
testing samples. The following subsections describe the three main components of the
framework in more details.
3.1. Feature selection
Not all the features are useful in classification. In fact, noisy features may decrease
imputation and classification accuracy. In this step, the noisy or redundant features in the
incomplete dataset are identified and removed through multi-task sparse regression (with
details provided later). However, due to the missing values in the dataset, we can not apply
sparse regression directly to the dataset. We first group the incomplete training set into
several overlapping submatrices that are comprised of samples with complete feature data
for different modality combinations, to which sparse regression algorithm can be applied.
Some parts of the submatrices are overlapping as we use a grouping strategy that uses the
maximum possible numbers of samples and features for each submatrix, so that as much
information as possible is used for sparse regression. For example, Table 3 shows the seven
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possible types of modality combination, denoted as “combination pattern” (CP), for a
dataset of 3 modalities, possibly with incomplete data. As shown in Table 3, a samples with
lower CP is a “subset” of some higher CPs, where these higher CPs contain modality data
that can be grouped with the lower CP to form a submatrix. For instance, the first row of
Table 3 indicates that CP1 is “subset” of CP3, CP5 and CP7, as CP1 contains only
“Modality 1” data, which is also part of CP3, CP5 and CP7’s data. Thus, we can combine
“Modality 1” data from CP3, CP5 and CP7 with CP1 to form a submatrix that contains the
maximum availability of samples with “Modality 1” data.
For the ADNI dataset used in this study, Modality 1, 2 and 3 are used to denote MRI, PET
and CSF, respectively. At ADNI baseline, MRI data is complete while PET and CSF data is
incomplete, resulting four possible types of data combination, i.e., CP1, CP3, CP5 and CP7.
Each CP can borrow data from the higher CPs as indicated in the last column of Table 3 to
form a submatrix. The graphical illustration of the submatrices is shown in Figure 2. The red
blocks in Figure 2 mark the four submatrices and their corresponding target outputs. Each
submatrix has four interrelated target outputs (i.e. 1 label and 3 clinical scores), which can
be learned together using a multi-task learning algorithm, by treating the prediction of each
output target as a task. Let Xi ∈ ℝni×di and Yi ∈ ℝni×ti denote the input submatrix and its
corresponding output matrix for the i-th multi-task learning in the training set, respectively.
Then the multi-task sparse regression of each submatrix is given as
(1)
where ni, di, ti and αi ∈ ℝdi×ti denote the number of samples, the number of features, the
number of target outputs and the weight matrix for the i-th multi-task learning, respectively.
‖.‖2,1 in Eq. (1) is the l2,1-norm (group-lasso (Yuan and Lin, 2006; Liu et al., 2009)) operator
which is defined as , where  denotes the k-th row of αi. The use of l2-
norm for  forces the weights corresponding to the k-th feature (of Xi) across multiple
tasks to be grouped together, while the subsequent use of l1-norm for  forces certain
rows of αi to be all zero. In other words, Eq. (1) tends to select only common features
(corresponding to non-zero-valued rows of αi) for all the prediction tasks. Thus, αi is a
sparse matrix with a significant number of zero-valued rows that correspond to redundant
and irrelevant features in each submatrix. In Figure 2, we arrange αi according to the feature
indices in X, so that the shaded rows in αi are corresponding to the columns in Xi (illustrated
by red block in the Figure), while the empty rows in αi are corresponding to the features not
included in Xi. In this way, each row of αi is corresponding to the same feature index in X.
The features that are selected for at least one of the submatrices (i.e., rows with at least one
non-zero value in [α1 α2 α3 α4]) are finally used for the training and the testing sets. In this
study, we determined αi for each multi-task learning by using 5-fold cross-validation test
based on the accuracy of the label (i.e., first column of Yi) prediction of the training
samples. The training and the testing sets with the selected features are then used in sample
selection as described in the following subsection.
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In this step, another multi-task learning is used to select representative samples from the
training set that are closely related to the samples in the testing set. This is similar to sparse
representation reported by other liter-atures (Huang and Aviyente, 2006; Wright et al.,
2010), a subset of samples is selected to represent a test sample. The only difference here is
that we perform sparse representation for a group of testing samples, instead of one testing
sample, to 1) select common samples from the training set that well represent the samples in
the testing set, and 2) remove unrelated or redundant samples from the training set. The
procedure of sample selection is similar to feature selection described previously, with some
modifications on the input and output matrices of the multi-task learning.
Let Xtr and Xte respectively denote the shrunk training and testing feature matrices from the
previous step that contain only the selected features. Xtr and Xte are first transposed (or
rotated by 90 degree) so that each column of XtrT and XteT contains features of a sample.
Then XtrT and XteT are used as the input and output to the multi-task learning, where the
task is now defined as the prediction of each testing sample from the training samples. If
there are no missing values in XtrT and XteT, this multi-task learning will select a set of
common samples (analogous to common features in feature selection) in the training set for
all the prediction tasks. However, due to the missing values in XtrT and XteT , we can not
perform sample selection directly. Instead, similar to feature selection, we group the input
matrix (XtrT ) into submatrices that contains complete data for the maximum possible
number of samples and features. For each submatrix in XtrT , all the samples in XteT that
contain the same set of input features are identified. Each pair of input submatrix and output
submatrix with the same features set forms a multi-task learning problem, with its
optimization equation given as
(2)
where , , βi ∈ ℝntri×ntei, , ntri and ntei denote the input
submatrix, output submatrix, weight matrix, length of the selected features, number of
training samples, and number of testing samples of the i-th multi-task learning, respectively.
Figure 3 summarizes the illustration of the sample selection. Note that the target matrix is
incomplete like the input matrix. This causes different number of targets for each multi-task
learning, which is reflected by different width of the weight matrix βi. Due to the use of
‖.‖2,1 term in Eq. (2), βi learned is a sparse matrix with some all-zero rows. Training subjects
corresponding to all-zero rows of [β1 β2 β3 β4] are removed as noisy/irrelevant samples. We
assume that removal of noisy or unrelated samples from the training set can consequently
improve the accuracy of the missing values imputation, and thus the classification
performance. To justify this assumption, we have included a simulation test on our proposed
sample selection algorithm using synthetic data in Appendix A.
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3.3. Matrix completion as classification
The original incomplete matrix is shrunk significantly after the feature and sample selection
steps. Let Xs and Ys denote the shrunk version of matrix X and Y, respectively, while ns and
ds denote the number of remaining samples and data features, respectively. The stacked
matrix Z = [Xs Ys] ∈ ℝns×(ds+t) still contains some missing values, including the target
outputs of the test set which are to be estimated. The objective of this step is to impute the
missing input features, missing target labels, and missing clinical scores simultaneously.
Two imputation methods are tested for this step, namely the modified Fixed-point
Continuation (FPC) algorithm (Goldberg et al., 2010; Ma et al., 2011) and the regularized
expectation maximization (EM) algorithm (Schneider, 2001).
3.3.1. Modified FPC (mFPC)—The multi-task regressions used in the features and
samples selection steps have selected the most discriminative input features for the (training)
target outputs and the most representative training samples for the testing samples,
respectively. As a consequence, the columns of target outputs (Ys) of the stacked matrix Z
could be linearly represented by the columns of data features (Xs); while the rows of the
testing samples in Z could be linearly represented by the rows of the training samples. The
matrix Z is thus probably low rank (as some rows could be represented by other rows, etc.).
However, in practice, measurements in Xs and Ys could contain certain level of noises.
Therefore, the incomplete Z can be completed using trace norm minimization (low trace
norm is often used to approximate low rank assumption), together with two regularization
terms (i.e., the second and third term in Eq. (3)) to penalize the noises in Xs and Ys. As the
objective of our study is prediction of target labels, we separate the data in Z into two parts:
1) the target labels (P), and 2) the rest of the data (Q). The regularization terms are changed
accordingly to have one logistic loss function (Lp(u, v) = log(1 + exp(−uv))) for the output
labels (as the output labels can only take value 1 or −1), and one square loss function (Lq(u,
v) = 1/2(u − v)2) for the rest of the data (as other data can take any value). The imputation
optimization problem is thus given as:
(3)
where ΩP and ΩQ denote the set of observed (i.e., non-missing) labels in Ys and the set of
observed values for the rest of the data, respectively; |.| denotes an operator for the number
of elements; ‖.‖* denotes an operator for the trace norm; and zij, pij and qij are the predicted
observed values, observed target labels and other observed data, respectively. λm and µ are
the positive parameters used to control the focus of the minimization problem in Eq. (3). If
λm is high, Eq. (3) will focus on minimizing the Lp term (second term); if µ is high, Eq. (3)
will focus on minimizing the trace norm term (i.e., stronger low rank assumption), and vice
versa.
This optimization problem is solved by using the modified FPC algorithm (Goldberg et al.,
2010), which consists of two alternating steps for each iteration k:
1. Gradient step:
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where S(·) is the matrix shrinkage operator. If SVD of Ak is given as UΛVT, then
the shrinkage operator is given as:
(7)
where max(·) is the elementwise maximum operator.
These two steps are iterated until convergence where the objective function in Eq. (3) at k-th
iteration is stable.
3.3.2. Regularized EM (rEM)—We also use the regularized EM (rEM) algorithm
developed in (Schneider, 2001) to impute missing values. Symbols defined in this
subsection should not be confused with the symbols used in other sections. Let X ∈ ℝn×d be
an incomplete matrix with n number of samples and d number of variables, its mean vector μ
∈ ℝ1×d and covariance matrix Σ ∈ ℝd×d are to be estimated. For a given sample x ∈ ℝ1×d
with missing values, let xm ∈ ℝ1×dm and xa ∈ ℝ1×da denote the parts of vector x containing
variables with missing values and available values, respectively. Then xm can be estimated
through linear regression model below
(8)
where µm ∈ ℝ1×dm and µa ∈ ℝ1×da represent the portions of μ that corresponding to xm and
xa, respectively, while B ∈ ℝda×dm and e ∈ ℝ1×dm are the regression coefficient matrix and
random residual vector (with zero mean and unknown covariance matrix C ∈ ℝdm×dm),
respectively. We are now ready to describe the imputation using EM algorithm, which is an
iterative process that consists of three steps, 1) expectation step: the mean μ and covariance
matrix Σ is estimated, 2) maximization step: the conditional maximum like-lihood estimate
(MLE) of the parameters of the regression model (i.e, B and C) is computed, based on the
expected value of μ and Σ, and, 3) imputation step: the missing values is estimated using (8)
based on the computed parameters. After missing values are imputed, it will iterate back to
step 1, where a new set of μ and Σ is estimated based on the completed x, and the whole
process is repeated until a convergence condition is met (i.e., the estimated μ and Σ become
stable). Regularized EM algorithm consists of the same steps as EM algorithm, with a
Thung et al. Page 10






















modification on the maximization step, where the regression coefficients in B are computed
through ridge regression method (Hoerl and Kennard, 1970). For more detailed information
about rEM algorithm, interested reader may refer to (Schneider, 2001). In our framework,
rEM is used to estimate unknown target outputs and missing input features in the matrix
completion step.
4. Results and discussions
The proposed framework was tested using the ADNI multi-modality dataset, which includes
MRI, PET and CSF data. In this section, the proposed framework is first compared with the
baseline frameworks which will be defined in the following subsection. Then, the proposed
framework is compared with two state-of-the-art methods (i.e., incomplete Multi-Source
Feature (iMSF) learning method and Ingalhalikar’s algorithm for classification based on
incomplete dataset) and also an unimodal classifier using only MRI features. In addition, we
evaluate the effect of parameters selection (i.e., λs, λm and µ) of the proposed framework on
the classification performance. Finally, we also identify the features that are always being
selected in this study.
The classification performance of all the compared methods is evaluated using a 10-fold
cross-validation scheme. For each fold, another 5-fold cross-validation scheme is applied on
the training dataset to select the best parameters for multi-task learning in feature selection
and also for sparse regression based classifier in the baseline methods. The multi-task
learning in feature selection and sample selection is realized by using matlab function
mcLeastR from SLEP4. SLEP is a powerful sparse learning package where it achieves fast
convergence in computation by using Nesterov’s method (Liu et al., 2009; Nesterov, 1983)
to solve smooth reformulation of the problem and accelerated gradient method (Nesterov,
2007; Liu and Ye, 2010) to solve regularized non-smooth optimization problem. There are
infinite choices for λf (i.e., multi-task learning parameter in feature selection). Fortunately
for the solver mcLeastR that we used, it automatically computes the maximum λmax value
for our problem. Thus, each λf value that we input to this solver is treated as a fraction to
λmax, e.g., the true regularization parameter used for λf = 0.1 is actually 0.1 × λmax.
Therefore, we choose parameter λf from these candidate values: {0.001, 0.005, 0.01, 0.05,
0.1, 0.15, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 }, which roughly cover the whole range of
possible λf values. The λf value used for each fold of experiment is determined based on the
highest accuracy of regressed Y label of the training data through 5-fold cross-validation test
on the training data. As a result, λf is different for each fold of experiment, i.e., different data
sparsity for each fold of experiment is assumed. For sample selection, we fix a small value
for λs, aiming to only remove unrelated samples from the training set. For mFPC matrix
completion algorithm, we use grid search to select values of its parameters (i.e., μ and λm),
i.e., fixed value of μ and λm are used for all the folds based on the best classification result in
grid search.
Four classification performance measures are used in this study, namely 1) accuracy: the
number of correctly classified samples divided by the total number of samples; 2)
4http://www.public.asu.edu/~jye02/Software/SLEP/index.htm
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sensitivity: the number of correctly classified positive samples divided by the total number
of positive samples; 3) specificity: the number of correctly classified negative samples
divided by the total number of negative samples; and 4) area under receiver operating
characteristic (ROC) curve (AUC). The positive samples are referred to AD in AD/NC
classification and MCI in MCI/NC classification, respectively.
4.1. Comparison with baseline frameworks
Four imputation methods are included in the baseline framework for comparison in this
study:
1. Zero imputation. In this method, the missing portion of the input data matrix is
filled with zero. Since all the features were z-normalized (i.e., with zero mean and
unit standard deviation) before the imputation process, “zero imputation” is
equivalent to fill the missing feature values with the average observed feature
values (i.e., all the missing values in a column of data matrix are filled with the
mean of the observed values in the same column).
2. k-nearest neighbor (KNN) imputation (Speed, 2003; Troyanskaya et al., 2001).
The missing values are filled with a weighted mean of the k nearest-neighbor rows.
The weights are inversely proportional to the Euclidean distances from the
neighboring rows. We set k = 20 after some empirical tests.
3. Regularized expectation maximization (rEM) (Schneider, 2001). Details are as
described in the previous section. We used the default parameter values for the
rEM code downloaded from http://www.clidyn.ethz.ch/imputation/index.html.
4. Fixed-point continuation (FPC) (Ma et al., 2011). FPC is one of the low rank
matrix completion method that uses the fixed point and Bregman iterative
algorithms. It is the original version of Eq. (3) with the regularization terms Lp and
Lq replaced by a square loss function for all the observed data. The matlab code for
FPC is included in the singular value thresholding (SVT) package5. The parameter
value of FPC, i.e., µ, is determined empirically.
These imputation methods are used in two baseline frameworks for comparisons:
1. Baseline 1: Conventional method. Impute the incomplete data matrix and then train
a classifier using the completed training set data.
2. Baseline 2: Use the proposed feature and sample selection method to shrink the
incomplete dataset, impute the missing features in the shrunk incomplete feature
matrix, and then train a classifier based on the completed shrunk training set data.
The only difference between the two baseline frameworks above, is that the first baseline
framework imputes missing values on the original feature matrix, while the second baseline
framework imputes missing values on the shrunk feature matrix. We use sparse regression
classifier for the two base-line frameworks, its formulation is given as:
5http://svt.stanford.edu/code.html
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where X, Y, and α are defined as the input feature matrix, the output target matrix (including
class labels and clinical scores), and the weight matrix, respectively. We obtain α based on
the completed training set and multiply it with the completed feature matrix from the testing
set to produce regressed outputs. The sign of the regressed output of a testing sample that
corresponds to the class label is used as the predicted class label. There is one regularization
parameter in Eq. (9), i.e., λ, which is always positive and is primarily used to control
features sparsity in X. We determine the value of λ by performing a 5-fold cross-validation
test based on the completed training dataset.
Table 4 summarizes the AD/NC classification performance of all the frameworks in
comparison. Results reported are the average measurements of 10 repetitions of 10-fold
cross-validation test. As shown in the Table 4, all performance of baseline 1 frameworks are
improved in baseline 2 framework (i.e., from 0.80–0.83 to 0.85–0.87). In fact, all the four
performance measures (i.e., accuracy, sensitivity, specificity and AUC) increase after
applying the proposed feature and sample selection steps before the imputation in base-line
2 framework. In addition, the average imputation time is significantly reduced, as shown in
the last column of Table 4. For example, FPC and rEM respectively complete the imputation
with 8 times and 4 times faster in the baseline 2 framework, if compared with the baseline 1
framework. We thus have shown the efficacy of the proposed feature and sample selection
methods in removing the unrelated samples and noisy features, which is beneficial to the
imputation process, both in terms of accuracy and speed. In addition, the classification
performance is further improved to 0.88–0.89 if the target labels are imputed simultaneously
with the incomplete data features using the modified FPC (mFPC) and rEM methods.
Although the classification performances of both mFPC and rEM are similar, mFPC
performs significantly better than rEM in terms of computation speed. Similar findings are
observed for MCI/NC classification as shown in Table 5.
4.2. Comparison with non-imputation state-of-the-art methods
Recently, several algorithms have been proposed to deal with incomplete dataset where the
data is missing in blocks. We compare our proposed frame-work with these methods, which
are briefly described in the following:
1. Incomplete Multi-source Feature learning (iMSF)6 (Yuan et al., 2012; Xiang et
al., 2013). The iMSF predicts the target output labels of the incomplete multiple
heterogeneous data without involving data imputation. This is a multi-task learning
algorithm that is able to deal with missing feature values. The iMSF is available in
two versions for multi-task learning part, i.e., the logistic version and the regression
version, along with one regularization parameter. We test both versions of iMSF
with a range of regularization parameters (i.e., {0.005, 0.01, 0.05, 0.1, 0.2, 0.3 and
6http://www.public.asu.edu/~jye02/Software/MALSAR/
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0.4}) and finally choose the one with the highest classification accuracy for
comparison.
2. Ingalhalikar’s algorithm (Ingalhalikar et al., 2012). This algorithm uses an
ensemble classification technique to fuse decision results from multiple classifiers
constructed from subsets of data. The data subsets are obtained by applying a
grouping strategy similar to ours. We implemented Ingalhalikar’s algorithm and
tested it on our dataset. Specifically, we group the data into subsets, select features
using signal-to-noise ratio coefficient filter (Guyon and Elisseeff, 2003), use linear
discriminant analysis (LDA) as classifier, and finally fuse all the classification
results of the subsets into a single result for each sample. We used two fusion
methods for this algorithm, i.e., 1) weighted average: each classifier is assigned a
weight based on its training classification error, 2) average: all the classifiers are
assigned with equal weight.
Tables 6 and 7 show the comparison of classification performance between the proposed
framework (using rEM and mFPC imputation methods) and the iMSF and Ingalhalikar’s
algorithm. Both tables shows that the proposed framework outperforms the Ingalhalikar’s
algorithm but performs competitively to iMSF.
iMSF-regression has the highest sensitivity for AD/NC classification and has the highest
specificity for MCI/NC classification. iMSF-logistic performs well in MCI/NC
classification, may be because that there is non-linear relationship between the features and
MCI, which can be better captured by logistic loss function. However, iMSF-logistic does
not perform as well in AD/NC classification, if compared with iMSF-regression and our
proposed methods. In addition, both versions of iMSF have lower AUC for both categories
of classification, if compared with our proposed methods.
Ingalhalikar’s algorithm has the lowest performance in this study if compared with iMSF
and our proposed method. The proposed framework, though not involving ensemble
procedure, is competitive with state-of-the-art algorithm.
The proposed framework performs the best in term of classification accuracy and AUC
values. In term of classification accuracy, the proposed framework using rEM performs the
best in AD/NC classification while the proposed framework using mFPC performs the best
in MCI/NC classification. Though the performance difference of the proposed framework
and iMSF is small in term of classification accuracy (about 1%), there is a sub-stantially
significant difference in term of AUC, which is not sensitive to threshold. Both mFPC and
rEM imputation algorithms achieve the highest AUC values for both AD/NC and MCI/NC
classifications, which are the most important measure in classification.
We performed additional t-tests to examine the significance of our results. We picked AUC
values for the t-test, as AUC values are not sensitive to threshold. All the AUC values
obtained from the 10 repetitions of the 10-fold cross-validation are used for comparisons,
i.e., 100 AUC values from the proposed methods, versus 100 AUC values from the methods
of comparison. The null hypothesis is that both methods have no significant difference in
term of AUC values, while the alternative hypothesis is there is significant difference in
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term of AUC values obtained by the two methods at 95% confidence level. We show the p-
values of the t-test at the last two columns of the Table 6 and Table 7. The p-values that are
marked with * indicates that the differences are significant at 95% confidence level.
Table 6 shows that our proposed framework using rEM and mFPC perform statistically
significantly better than all the methods in comparison in both the AD/NC and MCI/NC
classifications, in term of AUC values.
4.3. Comparison with unimodal classifier using MRI data
We also compare the performance of the proposed framework with a unimodal classifier
using only MRI data, as shown in Table 8. Since all the samples have MRI data, the number
of samples used is same as previous experiment. The same sparse regression classifier in Eq.
(9) is used in this test. Superior performance of the proposed framework demonstrates the
importance of including information from other modalities to improve disease diagnosis
accuracy.
4.4. Effect of parameters selection of mFPC
It is important to select a set of robust parameters for matrix completion, so that the
proposed framework works well for most of the situations. Figure 4 shows the classification
accuracies and AUC of the proposed mFPC-based framework for a range of λm and μ
values. As shown in the figure, the classification accuracy is consistently high when small μ
and large λm are used. With small μ and large λm, the objective function in Eq. (3) will focus
on the minimization of logistic function (i.e., target label prediction) instead of the
minimization of the trace norm (i.e., low rank matrix completion). This implies that the
incomplete matrix Z is completed using higher rank than expected. This is probably due to
the measurement noise in the dataset, which causes an increase in the rank of Z. Based on
the plot in Figure 4, Eq. (3) that satisfy μ ≤ 10−3 and λm ≥ 0.05 yield reasonably good label
prediction.
4.5. Effect of λs on sample selection
Figure 5 shows the effect of λs on sample selection in Eq. (2) to the average number of
samples selected (from the training dataset) and the average classification accuracy (i.e.,
accuracy of the label imputation) of the matrix completion. As shown in Figure 5, the
average number of samples selected reduces gradually when λs is decreasing, while
relatively consistent in terms of classification accuracy for mFPC. This implies that there are
a lot of redundant samples in the training set, which can be removed without significantly
affecting the accuracy of the label imputation. To examine the performance of sample
selection using synthetic data, please refer to Appendix A.
One of the possible limitations of the proposed sample selection is that the output space is
not considered in the algorithm (as this information is not available for the testing samples),
which might cause possible bias in the result if there is measurement noise in the output
space. For example, the feature space for highly coherent samples is very similar, but due to
measurement noise in the output space, they may have different outputs. In worst case
scenario (e.g., using too large λs value), the l1-regularized algorithms (i.e., the l1-norm part
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of the l2,1-norm) may select only one sample and discard the others, which cause bias in the
result. This problem can be ameliorated by including the additional l2-regularization, such as
that done in Elastic Net (Zou and Hastie, 2005). This will help retain some coherent samples
and allow some averaging effect. Another possible solution is to perform sample selection
and output variable estimation iteratively, which we leave it as our future work.
4.6. Most discriminative features
Table 9 shows the statistics of the features selected by the proposed feature selection method
for the incomplete ADNI data, during the AD/NC and MCI/NC classifications, respectively.
On average, more than 60% of the features is removed for both cases. The number of
features selected for each fold varied significantly, e.g., it can go as low as 45 or as high as
120 for AD/NC classification. This is probably because the regularization parameter λf in
Eq. (1) is chosen from a wide range of values (i.e., {0.001, …, 0.9}).
In addition, we also include the distribution of the most discriminative features according to
modalities in Table 9. We define the most discriminative features (MDFs) as the features
that were selected for more than 90% of the times, i.e., more than 90 times in the 10
repetitions of the 10-fold cross-validation run. Most of the MDFs are located in MRI
modality, for both the AD/NC and MCI/NC classifications. We also observed that more
features were selected for AD/NC than MCI/NC classification. This is probably because
MCI, which is the early stage of AD, affects less brain regions (or ROIs) if compared with
AD, where its abnormalities are widely spread across brain regions.
Table 10 shows the names of the MDFs for each modality. The common MDFs selected for
AD/NC and MCI/NC classifications are also included in Table 10, if exist. The common
MDFs for MRI modality include hippocampal formation, middle temporal gyrus, uncus, and
amygdala. The atrophy at these ROIs has been reported to be associated with memory and
cognitive impairments or closely related to the AD/MCI pathology (De Leon et al., 1997;
Convit et al., 2000; Yang et al., 2012; Poulin et al., 2011). For AD/NC classification, since
there are many MDFs from MRI, we only list the MDFs that were selected in all cross-
validations and repetitions in Table 10.
On the other hand, the common MDFs for FDG-PET modality include middle frontal gyrus
and precuneus, which are similar to the findings in (Mielke et al., 1998; Scarmeas et al.,
2004). For CSF biomarkers, the selected MDFs were t-tau/Aβ42 for AD/NC classification
and Aβ42 and t-tau for MCI/NC classification.
Figures 6 and 7 graphically show the locations of the selected ROI-based features (for MRI
and PET modalities) for both the AD/NC and MCI/NC classifications, respectively.
5. Conclusion
In this work, we propose a novel classification framework that is able to deal with datasets
with significant amount of missing data (e.g., data missing in blocks). Conventional
imputation-based classification approach is slow and inaccurate for this type of dataset. We
accomplish accurate label prediction by applying matrix completion on a shrunk version of
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the data matrix. The matrix shrinkage operation simplifies the imputation task since
redundant features and samples have been removed and less missing data needs to be
imputed. The experimental results demonstrate the efficacy of feature selection and sample
selection in improving the classification performance of the conventional imputation-based
classification method, both in terms of speed and accuracy. The proposed framework also
yields competitive performance, compared with the state-of-the-art methods such as iMSF
and Ingalhalikar’s algorithm. Based on the t-test of their AUC values, the proposed
framework using rEM and mFPC are statistically significantly better than iMSF and
Ingalhalikar’s algorithm in AD/NC and MCI/NC classifications.
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Appendix A. Test on sample selection algorithm using synthetic data
Sample selection was used in this work to select samples from the training set that are
closely related to the testing samples before imputation of missing values and class labels.
We assume that sample selection can remove outlier or unrelated samples from
inhomogeneous dataset, and consequently improves the classification performance. To
justify our assumption, we have tested the proposed sample selection algorithm by using
several sets of synthetic data. The synthetic data with ns number of samples, nf number of
variables and σ noise level, is generated as follows:
1. Generate a rank-r matrix Xr ∈ ℝns×nf by multiplying a randomly generated ns × r
matrix with another randomly generated r × nf matrix, where elements of both
matrices are drawn i.i.d. from a standard normal distribution.
2. Add Gaussian noise N(0, σ2) to each element of matrix Xr.
3. Generate a weight vector w ∈ ℝnf×1 where its elements are drawn i.i.d. from a
standard normal distribution.
4. Generate output label Y ∈ ℝnf×1 from Y = sign(Xr × w + N), where N is a noise
vector with its elements are drawn i.i.d. from N(0, σ2).
We simulated a multi-modal dataset by generating two different Xr with the same label Y,
and arranging them side by side, e.g., X = [Xr1Xr2]. We simulated heterogeneous dataset by
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generating several X with different rank or w, and stacking them together, e.g., Xhet = [X1;
X2], where X1 ∈ ℝns1 ×2nf and X2 ∈ ℝns2 ×2nf. We simulated missing data by randomly
removing half of the feature data (row by row) from the second modality of Xhet (i.e.,Xr2
part for both X1 and X2).
Table A.11 shows the details of the generated data. One homogeneous data and two
inhomogeneous (heterogeneous) data were generated. The homogenous data was created by
using a single matrix X1, the inhomogeneous data 1 was created by stacking X1 and X2,
while inhomogeneous data 2 was created by stacking X1, X2 and X3. Each Xm, m = {1, 2, 3}
is a “two-modality” simulated data, with each modality containing 80 features (i.e., nf = 80),
respectively. The rank for each modality data is shown in Table A.11. Each synthesized data
with four different levels of noise (i.e., σ = {2, 1, 0.5, 0.1}) were used in experiment.
We then tested our framework (specifically the sample selection algorithm) on the synthetic
data by using 10-fold cross-validation scheme, similar to the scheme used in this manuscript.
The simulation results using homogeneous and 2 types of inhomogeneous data are shown in
Figure A.8, A.9 and A.10, respectively. The x-axis of these figures is the λ in sample
selection, the higher the λ value, the more the removed training samples. The average
number of samples selected from the training set for each fold is shown at the bottom right
corner of all the three figures. The other three plots in these figures are the classification
accuracies versus λ, using mFPC, KNN and EM imputations, respectively. From the Figure
A.8, the classification accuracies for mFPC and KNN are rather stable for all the λ values, as
expected for homogeneous data. However, we surprisingly notice that the sample selection
improves the classification accuracies for EM imputation using incomplete homogeneous
data matrix. This is probably because sample selection removes some noisy samples from
the training samples that improves the EM imputation. From the Figure A.9, where the
number of “outlier” samples is about 10% of the total samples, the sample selection
algorithm slightly improves the classification accuracies for all the three imputation
methods, especially when the noise level in the data is higher, i.e., σ = {2, 1}. However, we
also notice that there are some declines in classification accuracies for low noise curves (σ =
{0.1, 0.5}) using KNN and EM imputations, when higher λ values are used. When the
number of “outlier” samples is increased to about 20% of the total samples, the classification
accuracies of mFPC and KNN improve significantly, particularly for data with higher noise
level, as shown in Figure A.10. The effect of sample selection on EM imputation is not
obvious for both the inhomogeneous data matrices 1 and 2.
In summary, these simulation results support our assumption that removing noisy samples
(due to Gaussian noise) or unrelated samples (due to inhomogeneous data) from the training
dataset can improve classification performance. Sample selection improves mFPC and KNN
imputation when the data is more noisy and inhomogeneous, while improves EM imputation
when the data is homogeneous.
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Synthetic data: One homogeneous data matrix and two inhomogeneous data matrices. Xm,m
= {1, 2, 3} is a simulated two-modality data matrix, e.g., [Xr1Xr2], with nsm number of
samples and rank (r1r2), where r1 and r2 are the ranks for Xr1 and Xr2, respectively. The
inhomogeneous data matrix 1 is simulated by stacking X1 and X2, while the inhomogeneous
data matrix 2 is simulated by stacking X1X2 and X3 data.
Data matrices X1 X2 X3
ns1 rank ns2 rank ns3 rank
Homogeneous 100 (60,40) 0 − 0 −
Inhomogeneous 1 100 (60,40) 10 (20,10) 0 −
Inhomogeneous 2 100 (60,40) 10 (20,10) 10 (10,10)
Figure A.8.
Classification result for homogenous data matrix.
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Classification result for inhomogeneous data matrix 1.
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Classification result for inhomogeneous data matrix 2.
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• Identify AD/MCI using incomplete dataset via matrix shrinkage and completion.
• A 2-step multi-task learning algorithm is used for feature and sample selection.
• Missing features and the unknown target labels are imputed simultaneously.
• Proposed feature and sample selection improves conventional imputation-based
methods.
• Proposed framework outperforms conventional methods in term of speed and
accuracy.
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Classification via matrix shrinkage and matrix completion. There are three main parts in this
framework: feature selection, sample selection and matrix completion. Note that feature
selection only involves training set. (Xs, Ys: Shrunk version of X and Y; Zc: Completed
version of Z.)
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Feature selection for incomplete multi-modal data matrix with multiple related target outputs
by first grouping the data into submatrices and then using multi-task learning on each
submatrix to extract common discriminative features. The red boxes come in pairs, which
mark the submatrices that are comprised of largest possible number of samples for each
pattern of modality combination and their corresponding target outputs.
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Sample selection. In this study, sample selection is realized by modifying the input and
output matrices in feature selection illustrated in Figure 2. Specifically, we transpose the
training and testing feature matrices, and use the transposed training and testing feature
matrices as the input and target output of the multi-task learning, respectively.
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Effect of the parameter changes in mFPC algorithm to AD/NC and MCI/NC classification
accuracies.
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Effect of the parameter λs on the number of samples selected and the corresponding
classification accuracies for AD/NC and MCI/NC classification using mFPC of the proposed
framework.
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MDFs in AD/NC classification. (Left: MRI, right: PET)
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MDFs in MCI/NC classification. (Left: MRI, right: PET)
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Table 2
Number of subjects (ADNI database at baseline) and number of features used in this study.
Modalities
MRI PET CSF All
Number of features 93 93 5 191
AD subjects 186 93 102 51
MCI subjects 395 203 192 99
NC subjects 226 101 112 52
Total subjects 807 397 406 202
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Table 3
Grouping of data according to maximum availability of samples for each combination pattern (CP) of
modalities. The availability of modalities is represented by binary number at the center column of the Table
(‘0’ denotes ‘missing’, ‘1’ denotes ‘available’), while its decimal equivalent is represented by the CP number
on the leftmost column of the Table. Samples with lower CP number can be grouped with the samples with
higher CP numbers at the last column of the Table to form a submatrix. In this study, the “Modality 1”,
“Modality 2” and “Modality 3” represent “MRI”, “PET” and “CSF”, respectively.
Combination pattern
(CP)
Availability of data Subset of
CP
Modality 1 Modality 2 Modality 3
1 1 0 0 3, 5, 7
2 0 1 0 3, 6, 7
3 1 1 0 7
4 0 0 1 5, 6, 7
5 1 0 1 7
6 0 1 1 7
7 1 1 1 −




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Thung et al. Page 42
Table 10
Most discriminative features (MDFs) selected for each modality. (Please refer to Table 9 for definition of
MDF. For MRI’s MDFs in AD/NC classification, only those that are selected 100% of the time are listed
here.)
Modality AD/NC MCI/NC
MRI Common MDFs: Hippocampal formation right, hippocampal formation left, middle temporal gyrus left, uncus left, amygdala
right.
Medial frontal gyrus, Angular gyrus
right, precuneus right, superior parietal lobule left, precentral gyrus left,
perirhinal cortex left, lateral occipitotemporal gyrus right, amygdala
left, middle temporal gyrus right,
corpus callosum, inferior temporal
gyrus right, lateral occipitotemporal
gyrus left.
Entorhinal cortex left, cuneus left,
lingual gyrus left, temporal pole left,
middle occipital gyrus left.
PET Common MDFs: Middle frontal gyrus right, precuneus right, precuneus left, Medial front-orbital gyrus right.
Insula right Angular gyrus left
CSF t-tau/Aβ42 Aβ42 and t-tau.
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